New Drug Combination Delays Breast Cancer Progression

Research presented at the 2014 San Antonio Breast Cancer Symposium reveals that a new drug combination for advanced breast cancer delays disease progression. A new combination of cancer drugs delayed disease progression for patients with hormone-receptor-positive metastatic breast cancer, according to a multi-center phase II trial. The findings of the randomized study (S6-03) were presented […]
The post New Drug Combination Delays Breast Cancer Progression appeared first on SciTech